Dr. Do-eun Lee, MD
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 27
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 840
Licensed in California since 2009, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CA license A107775 (first issued 2009; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Alta Bates Summit Medical Center - Alta Bates Camp Berkeley, CA
- Adventist Health Clearlake Clearlake, CA
- Sonoma Valley Hospital Sonoma, CA
- Providence Queen of the Valley Medical Center Napa, CA
- Adventist Health St Helena Saint Helena, CA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 840
- Services billed
- 22,867
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Injection, romosozumab-aqqg, 1 mg | 9,240 | 17 |
| Injection, denosumab, 1 mg | 4,382 | 59 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 1,127 | 204 |
| Established patient office or other outpatient visit, 30-39 minutes | 727 | 474 |
| Established patient office or other outpatient visit, 20-29 minutes | 325 | 266 |
| New patient office or other outpatient visit, 45-59 minutes | 208 | 208 |
| Injection of drug or substance under skin or into muscle | 129 | 81 |
| Ultrasound scan of head and neck soft tissue | 126 | 118 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 119 | 77 |
| Established patient office or other outpatient visit, 10-19 minutes | 42 | 29 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Napa, CA | 383 |
| Ozempic (semaglutide) Other prescribers in Napa, CA | 181 |
| Alendronate Sodium Other prescribers in Napa, CA | 145 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Napa, CA | 141 |
| Atorvastatin Calcium Other prescribers in Napa, CA | 101 |
| Mounjaro (tirzepatide) Other prescribers in Napa, CA | 91 |
| Testosterone Cypionate Other prescribers in Napa, CA | 88 |
| Methimazole Other prescribers in Napa, CA | 87 |
| Metformin Hcl Other prescribers in Napa, CA | 86 |
| Synthroid (levothyroxine sodium) Other prescribers in Napa, CA | 84 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 25 companies reported 115 payments worth $2,478 in total to this clinician.
| Novo Nordisk Inc | $342 |
|---|---|
| Amgen Inc. | $295 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $252 |
| Antares Pharma, Inc. | $249 |
| Madrigal Pharmaceuticals | $238 |
| Lilly USA, LLC | $167 |
| Bayer HealthCare Pharmaceuticals Inc. | $147 |
| Alexion Pharmaceuticals, Inc. | $139 |
| Food and Beverage | $2,478 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.